Browsing by Issue Date
Now showing items 1-1 of 1
Bone health in post-menopausal patients with breast cancer treated with aromatase inhibitors: factors predicting the risk for osteoporosis. (Stellenbosch : Stellenbosch University, 2018-12)ENGLISH ABSTRACT: Aromatase inhibitors (AI), the gold standard for treatment of postmenopausal women with hormone-sensitive breast cancer, add an additional burden to the risk of osteoporosis in the postmenopausal population. ...